BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

講師

偉喬生醫股份有限公司

 

Company Info

Name /Leadgene Biomedical, Inc.

Address /No.9, Ln. 147, Zhengbei 1st Rd., Yongkang Dist., Tainan City 710, Taiwan

Website /www.leadgenebio.com

Presenter

Name /Jay Wang

Title /Chief Strategy Officer (CSO)

Email /jay.wang@leadgene.com.tw

Telephone /02-27065528

Fax /06-2531536

Mobile /0988109696

Company Type

Biotechnology

About the Company

Based out of Tainan City, Taiwan, Leadgene Biomedical specializes in generating and engineering recombinant proteins and antibodies. We manufacture over 300 recombinant proteins in our ISO13485 plant and help our client with novel antibody discovery and platform development. We also have achieved CE Mark approval and registration for Leadgene® IS ELISA kit. And we provide excellent one-stop services, including ODM/OEM, pharmacokinetic measurement (Biacore and FOPPR), antibody development, and antibody engineering. Leadgene Biomedical will set up the cell line development to the next stage and develop CDMO and cell line development services to fuel Taiwan’s protein drug production.

Brief Description of main products or services

1. COVID-19 series products

Leadgene specializes in rare antibody development and manufactures high-quality proteins and antibodies in the ISO 13485 plant. In addition, we develop recombinant proteins carrying various mutants of SARS-CoV-2 variants. Leadgene pursues continuous improvement and fulfills the need of customers.

2. Recombinant proteins and antibodies for IVD raw materials

Leadgene possesses leading-edge technology in antibody design, engineering, and development. We manufacture over 300 high-quality recombinant proteins, including a comprehensive human cytokine panel for immunology and cancer research. In addition, we provide the GMP-grade proteins in our ISO 13485 certified plant. We offer high-quality, stable, and high-purity proteins and antibodies.

3. Cell line development

Leadgene Biomedical and CYTENA BPS initiated cooperation to fuel the early stage of protein drug development. By offering professional technology, we establish stabilized cell lines and characterize the cell-expressed proteins. We ensure our clients that they can obtain high-quality and accurate target proteins.

4. CDMO services

Leadgene provides the early-stage biologics development from transient transfection to cell culture scale-up. We also help our clients establish the platform development, including lateral flow (rapid test) development, ELISA kit development, etc. We provide the one-stop service with antigen design, antibody production, system setup, and manufacture.

Contact Person

Name /Angela Tai

Email /angelatch@leadgene.com.tw

Phone /06-2536677 ext: 221